The WorldWide Antimalarial Resistance Network (WWARN) is a multidisciplinary, global network of malaria research experts. WWARN works to provide the information necessary to prevent or slow antimalarial drug resistance, in turn, reducing the number of people falling ill and dying from malaria.
WWARN’s mission is to provide comprehensive, timely, quality-assured evidence to track the emergence and spread of malaria drug resistance, and improve the efficacy of existing antimalarial medicines and new drugs in development.
WWARN’s key activities include:
- Providing the malaria community with a reliable and standardised data collection platform to facilitate data sharing, pooled data analyses, and the application of these findings to provide evidence for policy makers and drug developers, to optimise the therapeutic life of existing and new antimalarial drugs;
- Collaborating with laboratories across the world to provide support and advice to improve the analysis of antimalarial drug regimens during clinical trials, and in turn, enhancing the overall quality of the research data captured;
- Supporting the international malaria research community through guidance, tools and training materials to support researchers in malaria endemic countries with the collection, analysis, interpretation, and dissemination of high quality evidence on malaria drug efficacy;
- Creating visualisation maps and tools to highlight research gaps and opportunities in our understanding of antimalarial drug resistance to help inform clinical trial development and research analysis;
- Increasing awareness and understanding of the need for effective tracking of the emergence and spread of antimalarial resistance.